Literature DB >> 27307060

Cytokines profile and its correlation with endothelial damage and oxidative stress in patients with type 1 diabetes mellitus and nephropathy.

Rodrigo M C Pestana1, Caroline P Domingueti1, Rita C F Duarte1, Rodrigo B Fóscolo2, Janice S Reis3, Ana Maria S Rodrigues4, Laís B Martins4, Lirlândia P Sousa1, Daniela P Lage5, Cláudia N Ferreira5, Adaliene V M Ferreira4, Ana P Fernandes1, Karina B Gomes6.   

Abstract

The aim of the present study was to investigate the association between the presence of albuminuria and cytokines profile with biomarkers of endothelial damage and oxidative stress in patients with type 1 diabetes mellitus (DM1). The sample was composed by 35 healthy individuals, 63 DM1 patients with normoalbuminuria (<30 mg of albumin/g of creatinine) and 62 DM1 patients with micro- and macroalbuminuria (≥30 mg of albumin/g of creatinine). Plasma and urinary cytokines (TNF-α, IL-6 and IL-10) and thrombomodulin levels were determined by ELISA. Oxidative status was evaluated using the TBARS and MTT assays. Diabetic patients were characterized by elevated levels of urinary cytokines TNF-α, IL-6 and IL-10. Those with macroalbuminuria presented significantly higher TNF-α and IL-10 urinary levels when compared to other groups. Urinary and plasmatic levels of TNF-α were positively correlated with plasma levels of cystatin C, creatinine, urea and albuminuria, while they were negatively correlated with estimated glomerular filtration rate. Urinary IL-10 levels proved positive correlation with fasting glucose, HbA1c, thrombomodulin and TBARS, while IL-6 plasma levels were positively correlated with HbA1c and albuminuria. Only urinary TNF-α levels were associated with the presence and severity of macroalbuminuria, after logistic regression analysis. This finding suggests that measurement of urinary TNF-α level may be helpful to evaluate progression to nephropathy in DM1 patients.

Entities:  

Keywords:  Albuminuria; Cytokines; Endothelial damage; Oxidative stress; Type 1 diabetes mellitus

Mesh:

Substances:

Year:  2016        PMID: 27307060     DOI: 10.1007/s12026-016-8806-x

Source DB:  PubMed          Journal:  Immunol Res        ISSN: 0257-277X            Impact factor:   2.829


  52 in total

Review 1.  Leukocyte recruitment and vascular injury in diabetic nephropathy.

Authors:  Elena Galkina; Klaus Ley
Journal:  J Am Soc Nephrol       Date:  2006-01-04       Impact factor: 10.121

2.  Determination of the antioxidant status of plasma from type 2 diabetic patients.

Authors:  Leonardo O Medina; Clara A Veloso; Erica de Abreu Borges; Camila Armond Isoni; Maria R Calsolari; Miriam M Chaves; José A Nogueira-Machado
Journal:  Diabetes Res Clin Pract       Date:  2007-01-31       Impact factor: 5.602

Review 3.  IL-6 signal transduction and its physiological roles: the signal orchestration model.

Authors:  D Kamimura; K Ishihara; T Hirano
Journal:  Rev Physiol Biochem Pharmacol       Date:  2003-04-05       Impact factor: 5.545

4.  Urinary markers of renal inflammation in adolescents with Type 1 diabetes mellitus and normoalbuminuria.

Authors:  D Z I Cherney; J W Scholey; D Daneman; D B Dunger; R N Dalton; R Moineddin; F H Mahmud; R Dekker; Y Elia; E Sochett; H N Reich
Journal:  Diabet Med       Date:  2012-10       Impact factor: 4.359

5.  Activated protein C protects against diabetic nephropathy by inhibiting endothelial and podocyte apoptosis.

Authors:  Berend Isermann; Ilya A Vinnikov; Thati Madhusudhan; Stefanie Herzog; Muhammed Kashif; Janusch Blautzik; Marcus A F Corat; Martin Zeier; Erwin Blessing; Jun Oh; Bruce Gerlitz; David T Berg; Brian W Grinnell; Triantafyllos Chavakis; Charles T Esmon; Hartmut Weiler; Angelika Bierhaus; Peter P Nawroth
Journal:  Nat Med       Date:  2007-11-04       Impact factor: 53.440

6.  Regulation of the IL-10 production by human T cells.

Authors:  K Rafiq; L Charitidou; D M Bullens; A Kasran; K Lorré; J Ceuppens; S W van Gool
Journal:  Scand J Immunol       Date:  2001-02       Impact factor: 3.487

7.  Urinary and renal interstitial concentrations of TNF-alpha increase prior to the rise in albuminuria in diabetic rats.

Authors:  Kambiz Kalantarinia; Alaa S Awad; Helmy M Siragy
Journal:  Kidney Int       Date:  2003-10       Impact factor: 10.612

8.  Relevance of TNF-α in the context of other inflammatory cytokines in the progression of diabetic nephropathy.

Authors:  Lin Sun; Yashpal S Kanwar
Journal:  Kidney Int       Date:  2015-10       Impact factor: 10.612

9.  Macrophage-derived tumor necrosis factor-α mediates diabetic renal injury.

Authors:  Alaa S Awad; Hanning You; Ting Gao; Timothy K Cooper; Sergei A Nedospasov; Jean Vacher; Patrick F Wilkinson; Francis X Farrell; W Brian Reeves
Journal:  Kidney Int       Date:  2015-06-10       Impact factor: 10.612

10.  Albumin antioxidant response to stress in diabetic nephropathy progression.

Authors:  Rafael Medina-Navarro; Itzia Corona-Candelas; Saúl Barajas-González; Margarita Díaz-Flores; Genoveva Durán-Reyes
Journal:  PLoS One       Date:  2014-09-04       Impact factor: 3.240

View more
  4 in total

1.  IL-6 and type 1 diabetes mellitus: T cell responses and increase in IL-6 receptor surface expression.

Authors:  Karina Braga Gomes
Journal:  Ann Transl Med       Date:  2017-01

Review 2.  The Prospective Application of Melatonin in Treating Epigenetic Dysfunctional Diseases.

Authors:  Seth Mikaye Monayo; Xin Liu
Journal:  Front Pharmacol       Date:  2022-05-20       Impact factor: 5.988

Review 3.  MicroRNAs in the Progress of Diabetic Nephropathy: A Systematic Review and Meta-Analysis.

Authors:  Li-Ping Wang; Yu-Zhen Gao; Bin Song; Guo Yu; Hui Chen; Zhen-Wen Zhang; Cai-Feng Yan; Yun-Long Pan; Xiao-Yan Yu
Journal:  Evid Based Complement Alternat Med       Date:  2019-03-07       Impact factor: 2.629

4.  Impaired Innate Immunity in Pediatric Patients Type 1 Diabetes-Focus on Toll-like Receptors Expression.

Authors:  Katarzyna Kurianowicz; Maria Klatka; Agnieszka Polak; Anna Hymos; Dominika Bębnowska; Martyna Podgajna; Rafał Hrynkiewicz; Olga Sierawska; Paulina Niedźwiedzka-Rystwej
Journal:  Int J Mol Sci       Date:  2021-11-09       Impact factor: 5.923

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.